文献速递甲状腺与颈部外科围术期管理与 ERAS

原发性甲状旁腺功能亢进中两种影像学特征与诊断性能差异

Differences in histopathologic features and diagnostic performance of 99mTc-methoxy-isobutyl-isonitrol single photon emission tomography-CT and 18F-fluorocholine positron emission tomography-CT in primary hyperparathyroidism.
PubMed 文献 · Surgery · 2025-08-08

该回顾性研究纳入245例原发性甲状旁腺功能亢进手术患者,比较99mTc-MIBI SPECT-CT与18F-氟胆碱PET-CT的诊断性能及组织病理特征。18F-氟胆碱PET-CT灵敏度93.1%、准确率78.8%,99mTc-MIBI SPECT-CT灵敏度70.4%、准确率60.7%。18F-氟胆碱PET-CT更常检出较小腺体且与主细胞为主相关,99mTc-MIBI SPECT-CT在嗜酸细胞和 oncocytic 腺瘤中摄取更高。

要点

  • 18F-氟胆碱PET-CT灵敏度93.1%、准确率78.8%,优于99mTc-MIBI SPECT-CT的70.4%和60.7%。
  • 18F-氟胆碱PET-CT更常识别较小腺体,并与主细胞为主相关。
  • 99mTc-MIBI SPECT-CT在嗜酸细胞和oncocytic腺瘤中放射性摄取更高。

核心结论

  • 18F-氟胆碱PET-CT在病灶定位中诊断性能高,尤其适用于一线影像阴性或不 conclusive 的患者。
  • 放射性示踪剂摄取可能受生化和形态学特征影响,但机制尚需进一步研究。

研究设计与样本

  • 回顾性研究,纳入2021年1月至2024年4月间接受甲状旁腺手术的245例原发性甲状旁腺功能亢进患者。
  • 影像学发现与生化数据、组织病理学和手术结果进行关联分析。
  • 分析半定量PET参数,并比较腺体大小、重量、细胞组成和生长模式。

主要发现

  • 18F-氟胆碱PET-CT灵敏度93.1%,诊断准确率78.8%。
  • 99mTc-MIBI SPECT-CT灵敏度70.4%,准确率60.7%。
  • 18F-氟胆碱PET-CT更常识别较小腺体,且更常与主细胞为主相关。
  • 99mTc-MIBI SPECT-CT在嗜酸细胞和oncocytic腺瘤中放射性摄取更高。
  • 最大标准化摄取值与甲状旁腺激素水平和腺体大小相关,但与细胞组成或生长模式无关。

临床怎么用

  • 对于99mTc-MIBI SPECT-CT阴性或结果不一致的原发性甲状旁腺功能亢进患者,可考虑18F-氟胆碱PET-CT进行术前定位。
  • 影像学检查选择时可结合预期腺体病理特征(如主细胞为主或嗜酸细胞腺瘤)进行个体化评估。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary hyperparathyroidism is a common endocrine disorder. Accurate preoperative localization is crucial for the success of minimally invasive parathyroidectomy. Although 99mTc-methoxy-isobutyl-isonitrol single photon emission computed tomography-computed tomography remains the gold standard imaging technique, its diagnostic performance can be limited in certain clinical scenarios. In recent years, 18F-fluorocholine positron emission tomography-computed tomography has emerged as a promising alternative, especially in cases where first-line imaging results are inconclusive or negative. However, the mechanisms contributing to its superior diagnostic performance remain incompletely understood. The study aims to assess the diagnostic accuracy of 18F-fluorocholine positron emission tomography-computed tomography in patients with negative or discordant 99mTc-methoxy-isobutyl-isonitrol single photon emission computed tomography-computed tomography results and to evaluate the biochemical and histopathologic characteristics of hyperfunctioning glands detected by each imaging modalities. METHODS: A retrospective study was performed of 245 primary hyperparathyroidism patients who underwent parathyroid surgery between January 2021 and April 2024. Imaging findings were correlated with biochemical data, histopathology, and surgical outcomes. Semiquantitative positron emission tomography parameters were analyzed and statistical comparisons were made regarding gland size, weight, cellular composition, and growth patterns. RESULTS: 18F-Fluorocholine positron emission tomography-computed tomography presented a sensitivity of 93.1% and a diagnostic accuracy of 78.8%. This imaging modality identified smaller glands and was more frequently associated with chief-cell predominance. 99mTc-methoxy-isobutyl-isonitrol single photon emission computed tomography-computed tomography demonstrated a sensitivity of 70.4% and an accuracy of 60.7%, with higher radiotracer uptake observed in oxyphilic and oncocytic adenomas. The maximum standardized uptake value correlated with parathyroid hormone levels and gland size but not with cellular composition or growth pattern. CONCLUSION: 18F-fluorocholine positron emission tomography-computed tomography demonstrates high diagnostic performance in lesion localization, particularly in patients with negative or inconclusive first-line imaging. These findings suggest that radiotracer uptake may be influenced by biochemical and morphologic features, although further studies are warranted to clarify these mechanisms.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Osorio-Silla I, González DM, Quiceno Arias HD, et al. Differences in histopathologic features and diagnostic performance of 99mTc-methoxy-isobutyl-isonitrol single photon emission tomography-CT and 18F-fluorocholine positron emission tomography-CT in primary hyperparathyroidism. Surgery. 2025. PMID: 40782725. doi:10.1016/j.surg.2025.109595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。